Fidelity Investments’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-14,961	Closed	-$1.83M	–	4400
2019 Q3	$1.83M	Hold	14,961	–	–	﹤0.01%	2287
2019 Q2	$4.47M	Sell	14,961 -3,388	-18%	-$1.41M	﹤0.01%	2125
2019 Q1	$8.26M	Sell	18,349 -1,695	-8%	-$742K	﹤0.01%	1928
2018 Q4	$9.16M	Buy	20,044 +110	+0.6%	+$68.2K	﹤0.01%	1832
2018 Q3	$18.1M	Buy	19,934 +556	+3%	+$367K	﹤0.01%	1717
2018 Q2	$11.4M	Buy	19,378 +154	+0.8%	+$100K	﹤0.01%	1910
2018 Q1	$12.5M	Buy	19,224 +15,483	+414%	+$11.6M	﹤0.01%	1896
2017 Q4	$1.37M	Hold	3,741	–	–	﹤0.01%	2411
2017 Q3	$1.15M	Hold	3,741	–	–	﹤0.01%	2403
2017 Q2	$1.79M	Hold	3,741	–	–	﹤0.01%	2359
2017 Q1	$4.66M	Hold	3,741	–	–	﹤0.01%	2187
2016 Q4	$1.51M	Hold	3,741	–	–	﹤0.01%	2412
2016 Q3	$1.56M	Hold	3,741	–	–	﹤0.01%	2406
2016 Q2	$1.75M	Hold	3,741	–	–	﹤0.01%	2406
2016 Q1	$1.93M	Hold	3,741	–	–	﹤0.01%	2394
2015 Q4	$2.94M	Hold	3,741	–	–	﹤0.01%	2337
2015 Q3	$5.13M	Hold	3,741	–	–	﹤0.01%	2163
2015 Q2	$7.51M	Buy	+3,741	New	+$9.55M	﹤0.01%	2127